Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1567-1573, doi:10.1016/j.jacc.2008.07.052
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benito, B.
Right arrow Articles by Brugada, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Benito, B.
Right arrow Articles by Brugada, J.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH: HEART RHYTHM DISORDER

Gender Differences in Clinical Manifestations of Brugada Syndrome

Begoña Benito, MD*, Andrea Sarkozy, MD{dagger}, Lluis Mont, MD, PhD*, Stephan Henkens, RN{dagger}, Antonio Berruezo, MD*, David Tamborero, BEng*, Dabit Arzamendi, MD*, Paola Berne, MD*, Ramon Brugada, MD, PhD{ddagger}, Pedro Brugada, MD, PhD{dagger} and Josep Brugada, MD, PhD*,*

* Cardiology Department, The Thorax Institute, Hospital Clínic, University of Barcelona, Barcelona, Spain
{dagger} Heart Rhythm Management Centre, Cardiovascular Institute, UZ Brussel, VUB Brussels, Belgium
{ddagger} Cardiovascular Genetics Center, Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada

Manuscript received June 23, 2008; accepted July 30, 2008.

* Reprint requests and correspondence: Dr. Josep Brugada, The Thorax Institute, Hospital Clínic, University of Barcelona, c/Villarroel 170, 08036, Barcelona, Spain (Email: jbrugada{at}clinic.ub.es).

Objectives: We sought to assess differences in phenotype and prognosis between men and women in a large population of patients with Brugada syndrome.

Background: A male predominance has been reported in the Brugada syndrome. No specific data are available, however, concerning gender differences in the clinical manifestations and their role in prognosis.

Methods: Patients with Brugada syndrome were prospectively included in the study. Data on baseline characteristics, electrocardiogram parameters before and after pharmacological test, and events in follow-up were recorded for all patients.

Results: Among 384 patients, 272 (70.8%) were men and 112 (29.2%) women. At inclusion, men had experienced syncope more frequently (18%) or aborted sudden cardiac death (6%) than women (14% and 1%, respectively, p = 0.04). Men also had greater rates of spontaneous type-1 electrocardiogram, greater ST-segment elevation, and greater inducibility of ventricular fibrillation (p < 0.001 for all). Conversely, conduction parameters and corrected QT intervals significantly increased more in women in response to sodium blockers (p = 0.03 and p = 0.001, respectively). During a mean follow-up of 58 ± 48 months, sudden cardiac death or documented ventricular fibrillation occurred in 31 men (11.6%) and 3 women (2.8%; p = 0.003). The presence of previous symptoms was the most important predictor for cardiac events in men, whereas a longer PR interval was identified among those women with a greater risk in this series.

Conclusions: Men with Brugada syndrome present with a greater risk clinical profile than women and have a worse prognosis. Although classical risk factors identify male patients with worse outcome, conduction disturbances could be a marker of risk in the female population.

Key Words: Brugada syndrome • gender • sudden cardiac death

Abbreviations and Acronyms
  CI = confidence interval
  ECG = electrocardiogram
  EPS = electrophysiological study
  GPD1-L = glycerol-3 phosphate dehydrogenase-1 like
  HR = hazard ratio
  ICD = implantable cardioverter-defibrillator
  Ito = potassium current
  QTc = corrected QT interval
  SCD = sudden cardiac death
  SUDS = sudden unexplained death syndrome
  VF = ventricular fibrillation


Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A40. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. S. Pagel, R. E. Lilly, and A. C. Nicolosi
Use of ECMO to temporize circulatory instability during severe Brugada electrical storm.
Ann. Thorac. Surg., September 1, 2009; 88(3): 982 - 983.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Benito, J. Brugada, R. Brugada, and P. Brugada
Reply
J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1569 - 1570.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement